|
ACRV
|
Acrivon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
AWH
|
Aspira Women's Health Inc.
|
US
|
NASDAQ
|
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GENE
|
Genetic Technologies Ltd
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
|
KZIA
|
Kazia Therapeutics Limited
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
US
|
NASDAQ
|
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
|
PSTV
|
Plus Therapeutics, Inc.
|
US
|
NASDAQ
|